PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
03-Feb-2020 GSK announces European Medicines Agency (EMA) accepted marketing authorisation application for belantamab mafodotin for the treatment of relapsed or refractory multiple myeloma GlaxoSmithKline plc
03-Feb-2020 GSK announces European Medicines Agency (EMA) accepted marketing authorisation application for belantamab mafodotin for the treatment of relapsed or refractory multiple myeloma GlaxoSmithKline plc
02-Feb-2020 Oxford Nanopore Sequencers Have Left UK for China, to Support Rapid, Near-sample Coronavirus Sequencing for Outbreak Surveillance Oxford Nanopore Technologies
01-Feb-2020 MYM Subsidiary, Sublime Culture Inc., Receives Cannabis Cultivation License From Health Canada MYM Nutraceuticals Inc.
31-Jan-2020 FDA Approves First Drug For Treatment Of Peanut Allergy For Children U.S. Food and Drug Administration
31-Jan-2020 Appendix 4C: Quarterly Cash Flow Report Benitec Biopharma Limited
31-Jan-2020 Sectra Ranked #1 by Customers in US and Canada - Wins New Awards Sectra, Inc
31-Jan-2020 AbbVie Receives Positive CHMP Opinion for MAVIRET® (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Weeks in Genotype 3, Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis AbbVie
31-Jan-2020 Syndax Announces $35.0 Million Offering of Common Stock and Enters Term Sheet for Loan with Hercules Capital for up to $30 Million Syndax Pharmaceuticals, Inc.
31-Jan-2020 Reich Insurance launches innovative online Life Sciences insurance quote portal Reich Insurance Group
30-Jan-2020 Coronavirus: New Gear Offers Protection For Patients And Healthcare Workers Radiation Shield Technologies
30-Jan-2020 Aprecia Appoints Amol Matharu Chief Scientific Officer Aprecia Pharmaceuticals
30-Jan-2020 AnPac Bio Announces Pricing of Initial Public Offering AnPac Bio-Medical Science Co., Ltd.
30-Jan-2020 GreenLight Opens New Location at Research Triangle Park in North Carolina GreenLight
30-Jan-2020 Vizgen Launches with $14M Series A Financing Led by ARCH Venture Partners and Northpond Ventures Vizgen
30-Jan-2020 Abbott's Tendyne(TM) Device Receives World's First CE Mark for Transcatheter Mitral Valve Implantation Abbott
30-Jan-2020 Key Biologics Fills Critical Leadership Positions for High-Growth Business Key Biologics
30-Jan-2020 Neogen, Angus Genetics launch improved Angus GS(SM) Neogen Corporation
30-Jan-2020 VistaGen Therapeutics Receives FDA Clearance of IND for Phase 2 Clinical Study of AV-101 as a Potential Treatment of Dyskinesia in Parkinson's Disease Patients VistaGen Therapeutics
30-Jan-2020 Agencies Expect Possible Treatments and Hope for a Coronavirus Vaccine as Soon as Three Months USA News Group